Xuemei Zuo
Overview
Explore the profile of Xuemei Zuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuo X, Zhang T, Dong X, Liu J, Liu Y
Food Res Int
. 2025 Mar;
203:115766.
PMID: 40022314
Lactiplantibacillus plantarum can activate aryl hydrocarbon receptor (AHR) signaling in the gut by metabolizing tryptophan, thereby counteracting inflammation. However, the tryptophan metabolic characteristics of microorganisms are strain-specific and significantly influence...
2.
Ding H, Shao J, Cao H, Xiao C, Tong M, Zuo X, et al.
Clin Chim Acta
. 2025 Feb;
570:120190.
PMID: 39961412
Background: This study was designed to increase the precision and clinical significance of serum creatinine (Cr) measurements by refining the detection methodology through comprehensive laboratory automation and by employing the...
3.
Cai Y, Zuo X, Zuo Y, Wu S, Pang W, Ma K, et al.
Front Immunol
. 2023 Apr;
14:1101854.
PMID: 37063877
Background: Both obesity (OB) and periodontitis (PD) are chronic non-communicable diseases, and numerous epidemiological studies have demonstrated the association between these two diseases. However, the molecular mechanisms that could explain...
4.
Luo Y, Yang X, Basourakos S, Zuo X, Wei D, Zhao J, et al.
Front Mol Biosci
. 2021 Nov;
8:652443.
PMID: 34746227
Previous studies showed that CXCR7 expression was upregulated after enzalutamide (ENZ) treatment, and an increased level of CXCR7 could increase the invasion, migration, and angiogenesis of castration-resistant prostate cancer (CRPC)...
5.
Luo Y, Li M, Zuo X, Basourakos S, Zhang J, Zhao J, et al.
Int J Oncol
. 2018 Apr;
52(6):1827-1840.
PMID: 29658569
Hypoxia-inducible factor‑1α (HIF‑1α) is known to play crucial roles in tumor radioresistance; however, the molecular mechanisms responsible for the promotion of tumor radioresistance by HIF‑1α remain unclear. β‑catenin is known...
6.
Lan L, Basourakos S, Cui D, Zuo X, Deng W, Huo L, et al.
Oncol Lett
. 2018 Jan;
14(6):7733-7738.
PMID: 29344218
All-trans-retinoic acid (ATRA) can enhance iodine uptake capability of thyroid tumors, but the mechanisms remain poorly understood. The aim of the present study was to investigate the effects of ATRA...
7.
Luo Y, Azad A, Karanika S, Basourakos S, Zuo X, Wang J, et al.
Int J Cancer
. 2017 Dec;
142(10):2163-2174.
PMID: 29277895
Previous studies have shown that increased levels of chemokine receptor CXCR7 are associated with the increased invasiveness of prostate cancer cells. We now show that CXCR7 expression is upregulated in...
8.
Li L, Karanika S, Yang G, Wang J, Park S, Broom B, et al.
Sci Signal
. 2017 May;
10(480).
PMID: 28536297
Cancers with loss-of-function mutations in or are deficient in the DNA damage repair pathway called homologous recombination (HR), rendering these cancers exquisitely vulnerable to poly(ADP-ribose) polymerase (PARP) inhibitors. This functional...
9.
Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, et al.
Cell Rep
. 2017 Feb;
18(8):1970-1981.
PMID: 28228262
Cell division cycle 6 (CDC6), an androgen receptor (AR) target gene, is implicated in regulating DNA replication and checkpoint mechanisms. CDC6 expression is increased during prostate cancer (PCa) progression and...
10.
Lan L, Basourakos S, Cui D, Zuo X, Deng W, Huo L, et al.
Oncol Rep
. 2016 Nov;
37(1):426-434.
PMID: 27840971
The present study investigated whether the efficacy of radioiodine therapy towards aggressive thyroid cancer cells was affected by β-catenin activity and associated with sodium/iodine symporter (NIS) localization. Human thyroid cancer...